URI1 and hepatocellular carcinoma: This finding supports the previous model of HCC driven by the prefoldin-like chaperone (URI), which displayed a reduction in Trp metabolites and Trp-metabolizing enzymes in parallel with the acquisition of growth-promoting pathways including phosphorylation of S6 kinase (also observed here, Fig. 1q)33.